Osiris Therapeutics (OSIR) Q4 2013 Results - Earnings Call Webcast

May.13.14 | About: Osiris Therapeutics, (OSIR)

Osiris Therapeutics (OSIR): Q1 EPS of -$0.02 beats by $0.02. Revenue of $10.1M (+146% Y/Y) beats by $1.35M.

The following audio is from a conference call that will begin on May 13, 2014 at 09:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.